Bioamber Inc. (BIOAQ) SEC Filing 8-K Material Event for the period ending Thursday, October 25, 2018

Bioamber Inc.

CIK: 1534287 Ticker: BIOAQ

View differences made from one to another to evaluate Bioamber Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Bioamber Inc..


Assess how Bioamber Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Bioamber Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

Bioamber Inc. provided additional information to their SEC Filing as exhibits

Ticker: BIOAQ
CIK: 1534287
Form Type: 8-K Corporate News
Accession Number: 0001193125-18-309191
Submitted to the SEC: Fri Oct 26 2018 4:55:58 PM EST
Accepted by the SEC: Fri Oct 26 2018
Period: Thursday, October 25, 2018
Industry: Industrial Organic Chemicals
  1. Financial Exhibit
  2. Other Events

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: